Evidence map›Paper›PMID 39764018›Full record

ArticlebioRxiv : the preprint server for biology2024

Chromosomal rearrangements and instability caused by the LINE-1 retrotransposon.

Carlos Mendez-Dorantes, Xi Zeng, Jennifer A Karlow, Phillip Schofield, Serafina Turner, Jupiter Kalinowski, Danielle Denisko, Eunjung Alice Lee, Kathleen H Burns, Cheng-Zhong Zhang

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Transposons disrupt genomic stability and trigger cancers.Frontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Carlos Mendez-DorantesDepartment of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.ORCID 0000-0002-8190-8568
Xi ZengDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, 02115, USA.
Jennifer A KarlowDepartment of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Phillip SchofieldDepartment of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Serafina TurnerDepartment of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Jupiter KalinowskiDepartment of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Danielle DeniskoDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, 02115, USA.
Eunjung Alice LeeDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, 02115, USA.
Kathleen H BurnsDepartment of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.ORCID 0000-0003-1620-3761
Cheng-Zhong ZhangDepartment of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.ORCID 0000-0003-4095-9796

Funding

Consequences of retrotransposition on genome integrityR01CA276112 · NCI · DANA-FARBER CANCER INST · PI KATHLEEN H BURNS, Alice Eunjung Lee · 2023 to 2026
$2.9M
Mechanism for endogenous retroelements to mimic ancient exogenous identities in aging and diseased human tissueDP2AG072437 · NIA · BOSTON CHILDREN'S HOSPITAL · PI LEE, EUNJUNG ALICE · 2020 to 2020
$2.7M
Characterizing the LINE-1 Retrotransposition-Replication ConflictR01CA240816 · NCI · DANA-FARBER CANCER INST · PI BURNS, KATHLEEN H · 2020 to 2024
$2.0M
Immunological consequences of LINE-1 expression in cancerR01CA289390 · NCI · GEORGE WASHINGTON UNIVERSITY · PI KATHLEEN H BURNS, Katherine B Chiappinelli · 2024 to 2026
$1.9M
Single Molecule Detection of L1 Insertions and IntermediatesUG3NS132127 · NINDS · DANA-FARBER CANCER INST · PI BERNSTEIN, BRADLEY EVAN, BURNS, KATHLEEN H · 2023 to 2024
$879k
NCI NIH HHS R01 CA240816NCI NIH HHS R01 CA276112NCI NIH HHS R01 CA289390NIA NIH HHS DP2 AG072437NINDS NIH HHS UG3 NS132127
6 · The paper itself

Abstract

LINE-1 (L1) retrotransposition is widespread in many cancers, especially those with a high burden of chromosomal rearrangements. However, whether and to what degree L1 activity directly impacts genome integrity is unclear. Here, we apply whole-genome sequencing to experimental models of L1 expression to comprehensively define the spectrum of genomic changes caused by L1. We provide definitive evidence that L1 expression frequently and directly causes both local and long-range chromosomal rearrangements, small and large segmental copy-number alterations, and subclonal copy-number heterogeneity due to ongoing chromosomal instability. Mechanistically, all these alterations arise from DNA double-strand breaks (DSBs) generated by L1-encoded ORF2p. The processing of ORF2p-generated DSB ends prior to their ligation can produce diverse rearrangements of the target sequences. Ligation between DSB ends generated at distal loci can generate either stable chromosomes or unstable dicentric, acentric, or ring chromosomes that undergo subsequent evolution through breakage-fusion bridge cycles or DNA fragmentation. Together, these findings suggest L1 is a potent mutagenic force capable of driving genome evolution beyond simple insertions.

Identifiers

PMID39764018
PMCPMC11702581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.